Brave Asset Management Inc Gilead Sciences, Inc. Transaction History

Brave Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$67.69 - $73.03 $387,457 - $418,023	-5,724 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $85,747 - $93,691	-1,351 Reduced 19.1%	5,724 $394,000
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $6,000 - $6,845	-100 Reduced 1.39%	7,075 $457,000
Q2 2020 Jul 23, 2020	SELL	$72.34 - $84.0 $76,318 - $88,620	-1,055 Reduced 12.82%	7,175 $552,000
Q1 2020 Apr 16, 2020	BUY	$62.63 - $80.22 $156,575 - $200,550	2,500 Added 43.63%	8,230 $615,000
Q3 2019 Oct 24, 2019	BUY	$62.51 - $69.0 $31,255 - $34,500	500 Added 9.56%	5,730 $363,000
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $114,459 - $128,352	1,850 Added 54.73%	5,230 $353,000
Q1 2019 May 03, 2019	BUY	$62.53 - $70.05 $211,351 - $236,769	3,380 New	3,380 $220,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $691,669 - $902,575	-11,425 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $24,948 - $27,622	-350 Reduced 2.97%	11,425 $882,000
Q2 2018 Jul 23, 2018	SELL	$64.88 - $75.68 $162,135 - $189,124	-2,499 Reduced 17.51%	11,775 $834,000
Q1 2018 Apr 26, 2018	SELL	$72.84 - $88.8 $241,828 - $294,816	-3,320 Reduced 18.87%	14,274 $1.08 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $546,574 - $641,600	-7,682 Reduced 30.39%	17,594 $1.26 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $1.82 Million - $2.16 Million	25,276	25,276 $2.05 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Brave Asset Management Inc with notifications on news.